Russia launched the export of the drug “Aviewer” for the treatment of coronavirus – the medication is delivered to Belarus, according to a press release of the Russian direct investment Fund (RDIF), which is involved in the development of a drug together with a group of companies “Chemrar”.
Partners announced the production in June, the first 100 thousand Russian drug “Avidavit”. This is significantly higher than the original production plan at the level of 60 thousand courses of treatment. So we have made the decision to start exporting.
“the Supply of the drug in June was implemented in 35 regions across Russia and in the Republic of Belarus. Soon the supply of “Avifauna” will also be implemented in the Republic of Kazakhstan, which has already reached agreements”, — stated in the message.
“we are holding negotiations on the supply of “Avifauna” in a number of countries in Latin America. Also interested in purchasing “Avifauna” I am CIS and the Middle East, other regions of the world,” said the Fund.
“Aviewer” — the first was the MoH drug against the coronavirus. He became the world’s first drug against the coronavirus that contains the active substance “Favipiravir”, and developed with the support of the FUND on the basis of Japanese medicine that was originally tested against severe forms of influenza. The drug from COVID-19 “Aviator” will be free for patients of OMC.
the RDIF and participates in the development of another drug. Holding “national immunobiological company” the state Corporation “rostec” and the Russian direct investment Fund will organize the production of drugs based on blood plasma for the treatment of COVID-19 at four sites in Perm, Nizhny Novgorod, Tomsk and Ufa.
the Company will begin production of the drug immunoglobulin that contains antibodies to the coronavirus SARS CoV-2. The medicine contains plasma donors undergoing coronavirus infethe calibre,